At EverythingALS, our mantra of “care to cure” is encapsulated in our Vision 2030 plan. Our mission transcends the conventional non-profit model, adopting a dynamic, for-profit mindset focused on achieving a singular, transformative goal: the eradication of ALS by the year 2030. This target year is not just a deadline, but a milestone driven intention, marking the moment we aim to render our services obsolete in a world liberated from ALS.
We’ll launch our initiatives, secure funding, expand our ecosystem, and kickstart pivotal research projects.
Our focus will be on enhancing our funding streams, completing the development of our core ecosystem, and taking our research efforts to the global stage.
We’ll aim to solidify our capital base, advance ongoing research, and establish a ‘fail fast’ approach to clinical testing.
With a financial foundation robust enough to support us through 2030, we’ll initiate clinical trials targeting 1-3 agents that have a high probability of success.
Our objectives include fast-tracking clinical trials for various ALS subtypes and showcasing successes against genetic variations of the disease.
We’ll focus on enhancing our drug development platform, achieving further successes against genetic forms of ALS, and advancing clinical trials for identified sporadic subtypes.
A fully scalable rapid drug development platform, showcasing successes across all known sporadic subtypes and genetic forms of ALS.
Our approach is methodical, underpinned by a robust management system that integrates objectives, timelines, and measures to ensure transparency and accountability.
Prioritizing repair, regeneration, and understanding the subtypes and root causes of ALS.
Concentrating on finding cures that not only eliminate the disease but also restore function, through rapid drug development.
Addressing all forms of ALS, ensuring our efforts benefit every individual affected by the disease.
Setting clear objectives, timelines, and measures to track progress and impact.
Vision 2030 is more than just a timeline; it’s a commitment to turning the tide against ALS. By focusing our efforts, resources, and research, we’re not just dreaming of a world without ALS—we’re actively building the path to make it a reality.
Eliminate or reduce neuronal, glial and axonal dysfunction
Repair or regenerate motor neurons, axons and glial
Promote and accelerate repair and regeneration
Return brain function and enhance quality of life
Restore nerve-muscle connection and communication
